Nesrine Trabelsi

405 citations
13 papers · 251 indexed · h-index 6

Nesrine Trabelsi

13 papers receiving 247 citations

Peers

Nesrine Trabelsi
Comparison fields: 5 of 44
  • Genetics 159
  • Cancer Research 83
  • Neurology 47
  • Structural Biology 4
  • Pulmonary and Respiratory Medicine 71
Replace Kay Ka-Wai Li with:
Kay Ka-Wai Li China
Stephanie Heim Germany
M Łysiak Sweden
Charlotte Bonnet France
Anja zur Mühlen Germany
Eshini Panditharatna United States
Sabine Gijsen Netherlands
Koki Aihara Japan
Jana Jaal Estonia
Taishi Nakamura Japan
Nesrine Trabelsi relative to Kay Ka-Wai Li China Kay Ka-Wai Li's profile →
Citations per field
00.5×4.2×
Kay Ka-Wai Li · 1×
Citations per year

Countries citing papers authored by Nesrine Trabelsi

Since Specialization
Citations

This map shows the geographic impact of Nesrine Trabelsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nesrine Trabelsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nesrine Trabelsi more than expected).

Fields of papers citing papers by Nesrine Trabelsi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nesrine Trabelsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nesrine Trabelsi. The network helps show where Nesrine Trabelsi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nesrine Trabelsi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nesrine Trabelsi Line = papers co-authored together Nesrine Trabelsi links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20224
2 20214
3 20204
4 20199
5 20196
6 2019176
7 201814
8 20182
9 201314
10 19974
11 199410
12
[The accelerated phase in Chediak-Higashi syndrome].
19903
13
[Burkitt's lymphoma in Tunisia. Apropos of 18 cases].
19851

About Nesrine Trabelsi

Nesrine Trabelsi is a scholar working on Cancer Research, Pharmaceutical Science and Urology, having authored 13 papers that have together received 251 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers), Epigenetics and DNA Methylation (2 papers), Glycosylation and Glycoproteins Research (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Cancer Research and Treatments (1 paper) and Glutathione Transferases and Polymorphisms (1 paper). The work is most often cited by research in Genetics (159 citations), Cancer Research (83 citations) and Neurology (47 citations). Nesrine Trabelsi has collaborated with scholars based in Tunisia, France and Italy. Frequent co-authors include François Ducray, Emmanuelle Uro‐Coste, Carole Colin, Aurélie Kamoun, Émeline Tabouret, Jean‐Yves Delattre, Claude‐Alain Maurage, Agustí Alentorn, Fabienne Escande and Karima Mokhtari. Their work appears in journals such as Environmental Health Perspectives, American Journal of Respiratory Cell and Molecular Biology and Aging Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026